サマリー

世界のNARS抗体市場規模は、2022年の100万米ドルから2029年には100万米ドルに成長すると予測されており、2023年から2029年にかけて年平均成長率%で成長すると予測されています。
患者基盤の拡大、NARS抗体医薬品の上市、抗体医薬品の浸透の増加、バイオ医薬品業界全体の継続的な規制が、NARS抗体市場の収益を増加させる主な要因となっています。
アスパラギンtRNAリガーゼ（NARS）はクラスIIのアミノアシルtRNA合成酵素ファミリーに属します。
LPI（LPインフォメーション）の最新刊調査レポート「NARS抗体産業予測」は、過去の売上高から2022年の世界のNARS抗体の総売上高を予測し、2023年から2029年までのNARS抗体の予測売上高を地域別・市場分野別に包括的に分析しています。NARS抗体の売上高を地域別、市場分野別、サブセクター別に分類し、世界のNARS抗体産業の詳細な分析を百万米ドル単位で提供しています。
本インサイトレポートでは、世界のNARS抗体の状況を包括的に分析し、製品区分、企業形成、収益、市場シェア、最新動向、M&A活動などに関する主要動向を明らかにしています。また、NARS抗体のポートフォリオと能力、市場参入戦略、市場でのポジション、地理的な足跡に焦点を当て、加速する世界のNARS抗体市場におけるこれらの企業の独自のポジションをより良く理解するために、主要グローバル企業の戦略を分析しています。
本インサイトレポートでは、NARS抗体の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測することで、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの質的・量的市場インプットに基づいた透明性の高い手法により、本調査予測は世界のNARS抗体の現状と将来の軌道について非常にニュアンスのある見解を提供します。
当レポートでは、NARS抗体市場の製品タイプ別、用途別、主要企業別、主要地域別および国別の包括的な概要、市場シェア、成長機会を紹介しています。
市場のセグメンテーション
タイプ別セグメンテーション
モノクローナル
ポリクローナル
用途別セグメンテーション
免疫化学（IHC）
免疫蛍光（IF）
免疫沈降(IP)
ウェスタンブロット（WB）
ELISA法
その他
本レポートではまた、市場を地域別に分けています：
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
メルク
サーモフィッシャーサイエンティフィック
プロテインテック・グループ
アビバ・システム・バイオロジー
ベシル・ラボラトリーズ
エピジェンテック
ライフスパン バイオサイエンス
バイオルート
レイバイオテック
アブカム
ノバス・バイオロジカルズ
プロサイ
アブクローナルテクノロジー
アブノバ・コーポレーション
バイオス
オリジーン・テクノロジー
リーディングバイオロジー
アメリカ合衆国バイオロジカル
サイノ・バイオロジカル
フアビオ
NSJバイオ試薬
景傑PTMバイオラボ
北京ソーラーバイオ
武漢ファインバイオテック

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global NARS Antibody Market Size 2018-2029
2.1.2 NARS Antibody Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 NARS Antibody Segment by Type
2.2.1 Monoclonal
2.2.2 Polyclonal
2.3 NARS Antibody Market Size by Type
2.3.1 NARS Antibody Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global NARS Antibody Market Size Market Share by Type (2018-2023)
2.4 NARS Antibody Segment by Application
2.4.1 Immunochemistry (IHC)
2.4.2 Immunofluorescence (IF)
2.4.3 Immunoprecipitation (IP)
2.4.4 Western Blot (WB)
2.4.5 ELISA
2.4.6 Others
2.5 NARS Antibody Market Size by Application
2.5.1 NARS Antibody Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global NARS Antibody Market Size Market Share by Application (2018-2023)
3 NARS Antibody Market Size by Player
3.1 NARS Antibody Market Size Market Share by Players
3.1.1 Global NARS Antibody Revenue by Players (2018-2023)
3.1.2 Global NARS Antibody Revenue Market Share by Players (2018-2023)
3.2 Global NARS Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NARS Antibody by Regions
4.1 NARS Antibody Market Size by Regions (2018-2023)
4.2 Americas NARS Antibody Market Size Growth (2018-2023)
4.3 APAC NARS Antibody Market Size Growth (2018-2023)
4.4 Europe NARS Antibody Market Size Growth (2018-2023)
4.5 Middle East & Africa NARS Antibody Market Size Growth (2018-2023)
5 Americas
5.1 Americas NARS Antibody Market Size by Country (2018-2023)
5.2 Americas NARS Antibody Market Size by Type (2018-2023)
5.3 Americas NARS Antibody Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NARS Antibody Market Size by Region (2018-2023)
6.2 APAC NARS Antibody Market Size by Type (2018-2023)
6.3 APAC NARS Antibody Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe NARS Antibody by Country (2018-2023)
7.2 Europe NARS Antibody Market Size by Type (2018-2023)
7.3 Europe NARS Antibody Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa NARS Antibody by Region (2018-2023)
8.2 Middle East & Africa NARS Antibody Market Size by Type (2018-2023)
8.3 Middle East & Africa NARS Antibody Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global NARS Antibody Market Forecast
10.1 Global NARS Antibody Forecast by Regions (2024-2029)
10.1.1 Global NARS Antibody Forecast by Regions (2024-2029)
10.1.2 Americas NARS Antibody Forecast
10.1.3 APAC NARS Antibody Forecast
10.1.4 Europe NARS Antibody Forecast
10.1.5 Middle East & Africa NARS Antibody Forecast
10.2 Americas NARS Antibody Forecast by Country (2024-2029)
10.2.1 United States NARS Antibody Market Forecast
10.2.2 Canada NARS Antibody Market Forecast
10.2.3 Mexico NARS Antibody Market Forecast
10.2.4 Brazil NARS Antibody Market Forecast
10.3 APAC NARS Antibody Forecast by Region (2024-2029)
10.3.1 China NARS Antibody Market Forecast
10.3.2 Japan NARS Antibody Market Forecast
10.3.3 Korea NARS Antibody Market Forecast
10.3.4 Southeast Asia NARS Antibody Market Forecast
10.3.5 India NARS Antibody Market Forecast
10.3.6 Australia NARS Antibody Market Forecast
10.4 Europe NARS Antibody Forecast by Country (2024-2029)
10.4.1 Germany NARS Antibody Market Forecast
10.4.2 France NARS Antibody Market Forecast
10.4.3 UK NARS Antibody Market Forecast
10.4.4 Italy NARS Antibody Market Forecast
10.4.5 Russia NARS Antibody Market Forecast
10.5 Middle East & Africa NARS Antibody Forecast by Region (2024-2029)
10.5.1 Egypt NARS Antibody Market Forecast
10.5.2 South Africa NARS Antibody Market Forecast
10.5.3 Israel NARS Antibody Market Forecast
10.5.4 Turkey NARS Antibody Market Forecast
10.5.5 GCC Countries NARS Antibody Market Forecast
10.6 Global NARS Antibody Forecast by Type (2024-2029)
10.7 Global NARS Antibody Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck NARS Antibody Product Offered
11.1.3 Merck NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific NARS Antibody Product Offered
11.2.3 Thermo Fisher Scientific NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Proteintech Group
11.3.1 Proteintech Group Company Information
11.3.2 Proteintech Group NARS Antibody Product Offered
11.3.3 Proteintech Group NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Proteintech Group Main Business Overview
11.3.5 Proteintech Group Latest Developments
11.4 Aviva Systems Biology
11.4.1 Aviva Systems Biology Company Information
11.4.2 Aviva Systems Biology NARS Antibody Product Offered
11.4.3 Aviva Systems Biology NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Aviva Systems Biology Main Business Overview
11.4.5 Aviva Systems Biology Latest Developments
11.5 Bethyl Laboratories
11.5.1 Bethyl Laboratories Company Information
11.5.2 Bethyl Laboratories NARS Antibody Product Offered
11.5.3 Bethyl Laboratories NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bethyl Laboratories Main Business Overview
11.5.5 Bethyl Laboratories Latest Developments
11.6 EpiGentek
11.6.1 EpiGentek Company Information
11.6.2 EpiGentek NARS Antibody Product Offered
11.6.3 EpiGentek NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 EpiGentek Main Business Overview
11.6.5 EpiGentek Latest Developments
11.7 LifeSpan BioSciences
11.7.1 LifeSpan BioSciences Company Information
11.7.2 LifeSpan BioSciences NARS Antibody Product Offered
11.7.3 LifeSpan BioSciences NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 LifeSpan BioSciences Main Business Overview
11.7.5 LifeSpan BioSciences Latest Developments
11.8 Biorbyt
11.8.1 Biorbyt Company Information
11.8.2 Biorbyt NARS Antibody Product Offered
11.8.3 Biorbyt NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Biorbyt Main Business Overview
11.8.5 Biorbyt Latest Developments
11.9 RayBiotech
11.9.1 RayBiotech Company Information
11.9.2 RayBiotech NARS Antibody Product Offered
11.9.3 RayBiotech NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 RayBiotech Main Business Overview
11.9.5 RayBiotech Latest Developments
11.10 Abcam
11.10.1 Abcam Company Information
11.10.2 Abcam NARS Antibody Product Offered
11.10.3 Abcam NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Abcam Main Business Overview
11.10.5 Abcam Latest Developments
11.11 Novus Biologicals
11.11.1 Novus Biologicals Company Information
11.11.2 Novus Biologicals NARS Antibody Product Offered
11.11.3 Novus Biologicals NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Novus Biologicals Main Business Overview
11.11.5 Novus Biologicals Latest Developments
11.12 ProSci
11.12.1 ProSci Company Information
11.12.2 ProSci NARS Antibody Product Offered
11.12.3 ProSci NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 ProSci Main Business Overview
11.12.5 ProSci Latest Developments
11.13 ABclonal Technology
11.13.1 ABclonal Technology Company Information
11.13.2 ABclonal Technology NARS Antibody Product Offered
11.13.3 ABclonal Technology NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 ABclonal Technology Main Business Overview
11.13.5 ABclonal Technology Latest Developments
11.14 Abnova Corporation
11.14.1 Abnova Corporation Company Information
11.14.2 Abnova Corporation NARS Antibody Product Offered
11.14.3 Abnova Corporation NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Abnova Corporation Main Business Overview
11.14.5 Abnova Corporation Latest Developments
11.15 Bioss
11.15.1 Bioss Company Information
11.15.2 Bioss NARS Antibody Product Offered
11.15.3 Bioss NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Bioss Main Business Overview
11.15.5 Bioss Latest Developments
11.16 OriGene Technologies
11.16.1 OriGene Technologies Company Information
11.16.2 OriGene Technologies NARS Antibody Product Offered
11.16.3 OriGene Technologies NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 OriGene Technologies Main Business Overview
11.16.5 OriGene Technologies Latest Developments
11.17 Leading Biology
11.17.1 Leading Biology Company Information
11.17.2 Leading Biology NARS Antibody Product Offered
11.17.3 Leading Biology NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Leading Biology Main Business Overview
11.17.5 Leading Biology Latest Developments
11.18 United States Biological
11.18.1 United States Biological Company Information
11.18.2 United States Biological NARS Antibody Product Offered
11.18.3 United States Biological NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 United States Biological Main Business Overview
11.18.5 United States Biological Latest Developments
11.19 Sino Biological
11.19.1 Sino Biological Company Information
11.19.2 Sino Biological NARS Antibody Product Offered
11.19.3 Sino Biological NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Sino Biological Main Business Overview
11.19.5 Sino Biological Latest Developments
11.20 HUABIO
11.20.1 HUABIO Company Information
11.20.2 HUABIO NARS Antibody Product Offered
11.20.3 HUABIO NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 HUABIO Main Business Overview
11.20.5 HUABIO Latest Developments
11.21 NSJ Bioreagents
11.21.1 NSJ Bioreagents Company Information
11.21.2 NSJ Bioreagents NARS Antibody Product Offered
11.21.3 NSJ Bioreagents NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 NSJ Bioreagents Main Business Overview
11.21.5 NSJ Bioreagents Latest Developments
11.22 Jingjie PTM BioLab
11.22.1 Jingjie PTM BioLab Company Information
11.22.2 Jingjie PTM BioLab NARS Antibody Product Offered
11.22.3 Jingjie PTM BioLab NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Jingjie PTM BioLab Main Business Overview
11.22.5 Jingjie PTM BioLab Latest Developments
11.23 Beijing Solarbio
11.23.1 Beijing Solarbio Company Information
11.23.2 Beijing Solarbio NARS Antibody Product Offered
11.23.3 Beijing Solarbio NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Beijing Solarbio Main Business Overview
11.23.5 Beijing Solarbio Latest Developments
11.24 Wuhan Fine Biotech
11.24.1 Wuhan Fine Biotech Company Information
11.24.2 Wuhan Fine Biotech NARS Antibody Product Offered
11.24.3 Wuhan Fine Biotech NARS Antibody Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Wuhan Fine Biotech Main Business Overview
11.24.5 Wuhan Fine Biotech Latest Developments
12 Research Findings and Conclusion